Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma

R Ettari, M Zappalà, S Grasso, C Musolino… - Pharmacology & …, 2018 - Elsevier
The ubiquitin-proteasome system (UPS) is the major non-lysosomal proteolytic system for
the degradation of abnormal or damaged proteins no longer required. The proteasome is …
被引用次数：100 相关文章

Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma.

R Ettari, M Zappalà, S Grasso, C Musolino… - PHARMACOLOGY & …, 2018 - iris.unime.it
The ubiquitin-proteasome system (UPS) is the major non-lysosomal proteolytic system for
the degradation of abnormal or damaged proteins no longer required. The proteasome is …

Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma

R Ettari, M Zappalà, S Grasso… - Pharmacology & …, 2018 - pubmed.ncbi.nlm.nih.gov
The ubiquitin-proteasome system (UPS) is the major non-lysosomal proteolytic system for
the degradation of abnormal or damaged proteins no longer required. The proteasome is …

[引用][C] Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma

R Ettari, M Zappalà, S Grasso, C Musolino… - Pharmacology & …, 2018 - cir.nii.ac.jp
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the
treatment of multiple myeloma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …